FDA Drug Application (202007) for ABACAVIR SULFATE; LAMIVUDINE by CIPLA LIMITED

Back to FDA Applications sponsored by CIPLA LIMITED

Application Number202007
Product Number001
FormTABLET, FOR SUSPENSION; ORAL
Dosage60MG; 30MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameABACAVIR SULFATE; LAMIVUDINE
Active IngredientABACAVIR SULFATE; LAMIVUDINE



Back to FDA Applications sponsored by CIPLA LIMITED

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.